This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Myocardial perfusion scintigraphy

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Myocardial perfusion scintigraphy uses a potassium analogue, thallium-201, to demonstrate areas of poorly perfused myocardium.

The investigation consists of a standard exercise test with continuous ECG and blood pressure monitoring. At peak exercise the thallium-201 is injected intravenously.

Areas of myocardium which are well perfused take up high levels of thallium while ischaemic areas appear as scintigraphic defects in the immediate post-exercise exposures.

Repeat imaging with the gamma-camera at 2-4 hr post-exercise permits reassessment of the scintigraphic defects:

  • if the defect has resolved then the area was relatively ischaemic but still viable
  • if the defect persists then the area has infarcted

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.